SEVEN EIGHT CAPITAL, LP - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 220 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$980,000
-60.0%
196,351
-42.7%
0.18%
-25.8%
Q3 2021$2,452,000
+123.7%
342,414
+189.5%
0.24%
+53.2%
Q2 2021$1,096,000
-63.4%
118,270
-65.1%
0.15%
-77.6%
Q1 2021$2,997,0000.0%338,6010.0%0.69%
+1.0%
Q4 2020$2,997,000
+1186.3%
338,601
+1587.8%
0.68%
+1264.0%
Q3 2020$233,00020,0620.05%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders